T. Rowe Price Target 2030 Fund Advisor Class
PAKRX
NASDAQ
Weiss Ratings | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Rating | ||||
Reward Index | Fair | |||
Reward Grade | C | |||
Risk Index | Fair | |||
Risk Grade | C | |||
Company Info | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Provider | T. Rowe Price | |||
Manager/Tenure (Years) | Wyatt A. Lee (11), Kimberly E. DeDominicis (5), Andrew G. Jacobs van Merlen (5) | |||
Website | http://www.troweprice.com | |||
Fund Information | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Fund Name | T. Rowe Price Target 2030 Fund Advisor Class | |||
Category | Target-Date 2030 | |||
Sub-Category | Target Date | |||
Prospectus Objective | Asset Allocation | |||
Inception Date | Aug 20, 2013 | |||
Open/Closed To New Investors | Open | |||
Minimum Initial Investment | 2,500.00 | |||
Minimum Subsequent Investment | 100.00 | |||
Front End Fee | -- | |||
Back End Fee | -- | |||
Dividends and Shares | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield | 2.34% | |||
Dividend | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Dividend Yield (Forward) | 1.99% | |||
Asset Allocation | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Cash | 5.57% | |||
Stock | 51.51% | |||
U.S. Stock | 35.23% | |||
Non-U.S. Stock | 16.28% | |||
Bond | 42.37% | |||
U.S. Bond | 33.29% | |||
Non-U.S. Bond | 9.08% | |||
Preferred | 0.15% | |||
Convertible | 0.09% | |||
Other Net | 0.31% | |||
Price History | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
7-Day Total Return | -0.95% | |||
30-Day Total Return | 3.35% | |||
60-Day Total Return | 0.41% | |||
90-Day Total Return | -0.13% | |||
Year to Date Total Return | 2.61% | |||
1-Year Total Return | 6.56% | |||
2-Year Total Return | 22.43% | |||
3-Year Total Return | 23.60% | |||
5-Year Total Return | 46.00% | |||
Price | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Closing Price | -- | |||
1-Month Low Price | -- | |||
1-Month High Price | -- | |||
52-Week Low Price | -- | |||
52-Week Low Price (Date) | -- | |||
52-Week High Price | -- | |||
52-Week High Price (Date) | -- | |||
NAV | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Nav | $14.50 | |||
1-Month Low NAV | $14.17 | |||
1-Month High NAV | $14.66 | |||
52-Week Low NAV | $13.39 | |||
52-Week Low NAV (Date) | Apr 08, 2025 | |||
52-Week High NAV | $15.19 | |||
52-Week High Price (Date) | Dec 04, 2024 | |||
Beta / Standard Deviation | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Beta | 0.59 | |||
Standard Deviation | 10.49 | |||
Balance Sheet | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Total Assets | 575.59M | |||
Operating Ratios | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Expense Ratio | 0.78% | |||
Turnover Ratio | 38.40% | |||
Performance | PAKRX-NASDAQ | Click to Compare |
Click to Compare |
Click to Compare |
Last Bull Market Total Return | 9.72% | |||
Last Bear Market Total Return | -10.95% | |||